WHY WORK WITH US?
We aren’t just partners, we are “Hybrid Integrators” – working directly with you from beginning to end, involved in your internal processes as much (or as little) as you wish. You decide, and we bring you solutions. We also seamlessly connect you with institutions for your Phase 1 studies.
MOLECULAR IMAGING SOLUTIONS
Our translational preclinical molecular imaging capabilities range from PET and SPECT to optical and luminescence imaging. Including static and dynamic (4D) imaging. With expertise in a plethora of therapeutic areas – we can provide your study needs.
DOWNLOADS, VIDEOS, RESOURCES & BLOG
Don’t need imaging? We can be a scientific resource – sharing information, networking, and posting some fun blogs along the way. Want to be interviewed for one of our articles? Just contact us – we would be happy to include you!
A few things we’re great at
At BioLaurus, we take pride in our expertise and specialization in the niche field of preclinical molecular imaging. And your needs are important to us – not just as a study, but as a scientific partner as well. We strive for excellence across all performance platforms – scientific, relational and budgetary. And we deliver.
We are in-vivo preclinical molecular imaging specialists. From discovery stage efficacy studies to follow-on safety/tox studies for clinical stage drugs, we have a demonstrated ability to develop innovative studies and assays, harnessing the power of in-vivo quantitative imaging.
Utilizing various modalities from gene expression and bioluminesence, to ultrasound and PET/SPECT (and more) – we offer a wide array of imaging solutions to provide you options which best meet your preclinical study needs.
STUDY DESIGN SERVICES
We create a unique imaging strategy, research plan, and study design for your specific needs. We then implement in BioLaurus approved and AAALAC accredited vivariums, in parallel with detailed protocol writing, on site monitoring, BioLaurus in-life study technicians, final data analysis and report. ALL of this is performed while working closely with you – to drive your strategies and goals towards successful study outcomes. We become part of YOUR TEAM.
NON-HUMAN PRIMATE STUDIES
Need NHP? We can provide solutions using various primate species, conducted in registered facilities and in accordance with local and global animal care and treatment guidelines. Specialties include PK/PD and Safety Studies utilizing SPECT or gamma camera imaging, platelet and T-cell radiolabeling, and more.
BioLaurus is a leader in the development of novel imaging assays and the adaptation of clinical imaging procedures to the preclinical research space. Bringing the power of quantitative in-vivo and longitudinal means getting the question right first, then assembling the technologies which provide you data-rich imaging for your assay.
Platelet Sequestration Studies
Several recent BioLaurus studies have focused on platelet sequestration in NHPs – assessing PLT distribution and clearance post-treatment.
Micro-CT Imaging is a 3D solution, offering resolution to 10-30um.
Lung tissue characteristics create low x-ray attenuation of air – results in high contrast.
Breakthrough technology could measure the rates of lipid absorption and secrtion in-vivo.
BioLaurus is a leader in the development of novel imaging assays.
Don’t take our word for it – here’s what our clients say:
The BioLaurus “Can-Do” philosophy, flexibility, and agility with study design changes afforded the opportunity to conduct investigative studies that were not possible with other clinical research organizations.
Husam Younis, PharmD, PhD
Senior Director, Nonclinical Development
Dr Bourdon is a distinguished Bio-imaging expert with extensive experience and knowledge of imaging technologies. With great attention to detail, the study was only performed once, with all goals met – allowing for swift publication.
Jeff (Ssucheng) Hsu, PhD
BioLaurus’ performance was outstanding in the study design and they provided trustworthy and insightful data and creative analysis techniques to get the most information from available data. I look forward to working with them in the future.
David Brewster, PhD, DABT
VP and Global Head – Drug Safety Evaluation
Check out our recent blogs about molecular imaging, preclinical studies, drug development – and plenty of other fun, related topics. If you have a suggestion for a blog (or would like to be interviewed), let us know!